Physician profile
Laszlo Hoesel
NPI 1447452057
$12,502.07
in general payments reported to CMS, 2019-2025
9 companies · $2,593 in 2025
The $2,593 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,791 · 2020: $1,768 · 2021: $670 · 2022: $272 · 2023: $4,489 · 2024: $920 · 2025: $2,593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,500 · Travel and Lodging: $3,439 · Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,500.00 |
| Travel and Lodging | $3,438.64 |
| Food and Beverage | $1,063.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,337.48 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,808.66 | 2020-2024 | Matrixorthognathic |
| Kls-Martin L.P. | $961.56 | 2019 | |
| Davol INC. | $949.33 | 2019-2023 | Phasix Mesh |
| Zimmer Biomet Holdings, INC. | $751.13 | 2019 | |
| Stryker Corporation | $670.10 | 2021 | |
| Tela Bio, INC. | $548.50 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Depuy Synthes Sales INC. | $375.79 | 2019-2024 | Matrixrib |
| Acera Surgical, INC. | $99.52 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laszlo Hoesel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.